Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/ Национального общества по изучению сердечной недостаточности и заболеваний миокарда (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2024)

Автор: Терещенко С.Н., Жиров И.В., Ускач Т.М., Саидова М.А., Голицын С.П., Римская Е.М., Насонова С.Н., Нарусов О.Ю., Сафиуллина А.А., Терещенко А.С., Стукалова О.В.

Журнал: Евразийский кардиологический журнал @eurasian-cardiology-journal

Рубрика: Клинические рекомендации

Статья в выпуске: 2, 2024 года.

Бесплатный доступ

Целью настоящего руководства является содействие врачам-кардиологам в ведении пациентов с хронической сердечной недостаточностью (СН) в соответствии с имеющейся современной доказательной базой. Настоящее руководство содержит данные по диагностике, лечению, реабилитации пациентов с хронической сердечной недостаточностью и данные по острой декомпенсации сердечной недостаточности.

Xроническая сердечная недостаточность, натрийуретические пептиды, фракция выброса левого желудочка, диагностика, медикаментозная терапия, немедикаментозная терапия, сочетанная патология, декомпенсация, фибрилляция предсердий, клинические рекомендации

Еще

Короткий адрес: https://sciup.org/143182953

IDR: 143182953   |   DOI: 10.38109/2225-1685-2024-2-6-76

Список литературы Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/ Национального общества по изучению сердечной недостаточности и заболеваний миокарда (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2024)

  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. https://doi.org/10.1093/eurheartj/ehab368
  • Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition o. Eur J Heart Fail 2021;23:352-80. https://doi.org/10.1002/ejhf.2115
  • Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart Failure With Recovered Left Ventricular Ejection Fraction. J Am Coll Cardiol 2020;76:719-34. https://doi.org/10.1016/j.jacc.2020.05.075
  • Фомин ИВ. Артериальная гипертония в Российской Федерации - последние 10 лет. Что дальше? Сердце: журнал для практикующих врачей. 2007;3(6):120-123. [Fomin I.V. Arterial hypertension in the Russian Federation - the last 10 years. What's next? Heart: a magazine for medical practitioners. 2007;3(6):120-123. (in Russ.)]
  • Ситникова М.Ю., Лясникова Е.А., Юрченко А.В., Трукшина М.А., Либис Р.А., КондратенкО В.Ю., Дупляков Д.В., Хохлунов С.М., Шляхто Е.В. Результаты Российского госпитального регистра хронической сердечной недостаточности в 3 субъектах Российской Федерации. Кардиология 2015;10:5- 13. https://doi.org/10.18565/cardio.2015.10.5-13
  • Поляков Д.С., Фомин И.В., Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Артемьева Е.Г., Бадин Ю.В., Бакулина Е.В., Виноградова Н.Г., Галявич А.С., Ионова Т.С., Камалов Г.М., Кечеджиева С.Г., Козиолова Н.А., Маленкова В.Ю., Мальчикова С.В., Мареев Ю.В., Смирнова Е.А., Тарловская Е.И., Щербинина Е.В., Якушин С.С. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14. https://doi.org/10.18087/cardio.2021.4.n1628
  • Cleland J. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63. https://doi.org/10.1016/S0195668X(02)00823-0
  • Lam CSP, Solomon SD. The middle child in heart failure: heart failure with midrange ejection fraction (40-50%). Eur J Heart Fail 2014;16:1049-55. https:// https://doi.org/doi.org/10.1002/ejhf.159
  • Lund LH, Claggett B, Liu J, Lam CS, Jhund PS, Rosano GM, et al. Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail 2018;20:1230-9. https://doi.org/10.1002/ejhf.1149
  • Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2019;381:1609-20. https://doi.org/10.1056/NEJMoa1908655
  • Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, et al. A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction. Eur J Heart Fail 2017;19:1624-34. https://doi.org/10.1002/ejhf.945
  • Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, et al. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction. Circ Hear Fail 2017 Jun;10(6):e003875. https:// https://doi.org/doi.org/10.1161/CIRCHEARTFAILURE.117.003875
  • Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. JACC Hear Fail 2016;4:464-72. https://doi.org/10.1016/j.jchf.2016.02.017
  • Агеев Ф.Т., Овчинников А.Г. Диастолическая сердечная недостаточность: 20 лет спустя. Актуальные вопросы патогенеза, диагностики и лечения сердечной недостаточности с сохраненной ФВ ЛЖ. Кардиология. 2023;63(3):3-12. https://doi.org/10.18087/cardio.2023.3.n2376
  • Терещенко С. Н., Жиров И. В., Нарусов О. Ю., Мареев Ю. В., Затейщиков Д.А., Осмоловская Ю. Ф., Овчинников А. Г., Самко А. Н., Насонова С. Н., Стукалова О. В., Саидова М. А., Скворцов А. А., Шариат М. А. ЮИС. Диагностика и лечение хронической и острой сердечной недостаточности. Кардиологический бюллетень 2016:2(11):3-33.
  • McMurray JJV. Systolic Heart Failure. N Engl J Med 2010;362:228-38. https://doi.org/10.1056/NEJMcp0909392
  • Chen J, Normand S-LT, Wang Y, Krumholz HM. National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008. JAMA 2011;306:1669. https://doi.org/10.1001/jama.2011.1474
  • Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, et al. Hospitalizations After Heart Failure Diagnosis. J Am Coll Cardiol 2009;54:1695-702. https://doi.org/10.1016/j.jacc.2009.08.019
  • Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, et al. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community. JACC Hear Fail 2016;4:808-15. https://doi.org/10.1016/j.jchf.2016.05.001
  • Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2004;43:317-27. https://doi.org/10.1016/j.jacc.2003.07.046
  • Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, et al. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. Int J Cardiol 2014;173:163-9. https://doi.org/10.1016/j.ijcard.2014.02.018
  • Cowie M. Hospitalization of patients with heart failure. A population-based study. Eur Heart J 2002;23:877-85. https://doi.org/10.1053/euhj.2001.2973
  • McAlister FA, Teo KK, Taher M, Montague TJ, Humen D, Cheung L, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999;138:87-94. https://doi.org/10.1016/S0002-8703(99)70251-6
  • Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, et al. Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction. Circulation 2015;131:269-79. https://doi.org/10.1161/CIRCULATIONAHA.114.010637
  • Rosch S, Kresoja K-P, Besler C, Fengler K, Schöber AR, von Roeder M, et al. Characteristics of Heart Failure With Preserved Ejection Fraction Across the Range of Left Ventricular Ejection Fraction. Circulation 2022;146:506-18. https://doi.org/10.1161/CIRCULATIONAHA.122.059280
  • Wehner GJ, Jing L, Haggerty CM, Suever JD, Leader JB, Hartzel DN, et al. Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? Eur Heart J 2020;41:1249-57. https://doi.org/10.1093/eurheartj/ehz550
  • Stewart S, Playford D, Scalia GM, Currie P, Celermajer DS, Prior D, et al. Ejection fraction and mortality: a nationwide register‐based cohort study of 499 153 women and men. Eur J Heart Fail 2021;23:406-16. https://doi.org/10.1002/ejhf.2047
  • Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75. https://doi.org/10.1093/eurheartj/ehi555
  • Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, et al. Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction. Circ Hear Fail 2011;4:27-35. https://doi.org/10.1161/CIRCHEARTFAILURE.109.932996
  • Ketchum ES, Levy WC. Establishing Prognosis in Heart Failure: A Multimarker Approach. Prog Cardiovasc Dis 2011;54:86-96. https://doi.org/10.1016/j.pcad.2011.03.003
  • Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15. https://doi.org/10.1161/01.CIR.88.1.107
  • Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;(8):7-13. https://doi.org/10.15829/1560-4071-2016-8-7-13
  • Wedel H, McMurray JJV, Lindberg M, Wikstrand J, Cleland JGF, Cornel JH, et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail 2009;11:281-91. https://doi.org/10.1093/eurjhf/hfn046
  • Allen LA, Felker GM, Pocock S, McMurray JJV, Pfeffer MA, Swedberg K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009;11:170-7. https://doi.org/10.1093/eurjhf/hfn031
  • Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543-50. https://doi.org/10.1016/S0140-6736(09)61378-7
  • Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeffer MA, et al. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure. J Am Coll Cardiol 2007;50:40-7. https://doi.org/10.1016/j.jacc.2007.02.067
  • Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. ESC Hear Fail 2014;1:4-25. https://doi.org/10.1002/ehf2.12005
  • Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics-2016 Update. Circulation 2016;133. https://doi.org/10.1161/CIR.0000000000000350
  • Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the Impact of Heart Failure in the United States. Circ Hear Fail 2013;6:606-19. https://doi.org/10.1161/HHF.0b013e318291329a
  • Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, et al. Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction. Circulation 2012;126:65-75. https://doi.org/10.1161/CIRCULATIONAHA.111.080770
  • Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, et al. Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction. Circulation 2009;119:3070-7. https://doi.org/10.1161/CIRCULATIONAHA.108.815944
  • Paulus WJ, Tschöpe C. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2013;62:263-71. https://doi.org/10.1016/j.jacc.2013.02.092
  • Redfield MM. Heart Failure with Preserved Ejection Fraction. N Engl J Med 2017;376:896-7. https://doi.org/10.1056/NEJMc1615918
  • Paulus WJ, Dal Canto E. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. JACC Hear Fail 2018;6:1-7. https://doi.org/10.1016/j.jchf.2017.07.012
  • Dhingra A, Garg A, Kaur S, Chopra S, Batra JS, Pandey A, et al. Epidemiology of Heart Failure with Preserved Ejection Fraction. Curr Heart Fail Rep 2014;11:354-65. https://doi.org/10.1007/s11897-014-0223-7
  • Liu M, Fang F, Yu C-M. Noncardiac Comorbidities in Heart Failure With Preserved Ejection Fraction - A Commonly Ignored Fact. Circ J 2015;79:954-9. https://doi.org/10.1253/circj.CJ-15-0056
  • Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2017;14:591-602. https://doi.org/10.1038/nrcardio.2017.65
  • Davie A. Assessing diagnosis in heart failure: which features are any use? QJM 1997;90:335-9. https://doi.org/10.1093/qjmed/90.5.335
  • Mant J, Doust J, Roalfe A, Barton P, Cowie M, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess (Rockv) 2009 Jul;13(32):1-207 https://doi.org/10.3310/hta13320
  • Oudejans I, Mosterd A, Bloemen JA, Valk MJ, van Velzen E, Wielders JP, et al. Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 2011;13:518-27. https://doi.org/10.1093/eurjhf/hfr021
  • Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev 2006;11:95- 107. https://doi.org/10.1007/s10741-006-9481-0
  • Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KGM, et al. The Diagnostic Value of Physical Examination and Additional Testing in Primary Care Patients With Suspected Heart Failure. Circulation 2011;124:2865-73. https://doi.org/10.1161/CIRCULATIONAHA.111.019216
  • Thibodeau JT, Turer AT, Gualano SK, Ayers CR, Velez-Martinez M, Mishkin JD, et al. Characterization of a Novel Symptom of Advanced Heart Failure: Bendopnea. JACC Hear Fail 2014;2:24-31. https://doi.org/10.1016/j.jchf.2013.07.009
  • Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 2019;21:715-31. https://doi.org/10.1002/ejhf.1494
  • Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ V., et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ 2015;350:h910-h910. https://doi.org/10.1136/bmj.h910
  • Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study. Eur J Heart Fail 2005;7:537-41. https://doi.org/10.1016/j.ejheart.2005.01.022
  • Fuat A, Murphy JJ, Hungin APS, Curry J, Mehrzad AA, Hetherington A, et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 2006;56:327-33. PMID: 16638247.
  • Yamamoto K, Burnett JC, Bermudez EA, Jougasaki M, Bailey KR, Redfield MM. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 2000;6:194-200. https://doi.org/10.1054/jcaf.2000.9676
  • Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53. https://doi.org/10.1016/S0140-6736(97)06031-5
  • Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-9. https://doi.org/10.1016/S0002-9343(01)00841-5
  • Kelder JC, Cramer MJ, Verweij WM, Grobbee DE, Hoes AW. Clinical Utility of Three B-Type Natriuretic Peptide Assays for the Initial Diagnostic Assessment of New Slow-Onset Heart Failure. J Card Fail 2011;17:729-34. https://doi.org/10.1016/j.cardfail.2011.04.013
  • Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-91. https://doi.org/10.1016/S0735-1097(00)01157-8
  • McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study. Am J Kidney Dis 2003;41:571-9. https://doi.org/10.1053/ajkd.2003.50118
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016;37:2129-200. https://doi.org/10.1093/eurheartj/ehw128
  • Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013;34:816-29. https://doi.org/10.1093/eurheartj/ehs224
  • Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, et al. Iron status in patients with chronic heart failure. Eur Heart J 2013;34:827-34. https://doi.org/10.1093/eurheartj/ehs377
  • Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 2014;35:455-69. https://doi.org/10.1093/eurheartj/eht386
  • Filippatos G, Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J 2014;35:416-8. https://doi.org/10.1093/eurheartj/eht515
  • Desai AS. Hyperkalemia in patients with heart failure: Incidence, prevalence, and management. Curr Heart Fail Rep 2009;6:272-80. https://doi.org/10.1007/s11897-009-0037-1
  • Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of Hemoglobin A1C and Mortality in Heart Failure Patients With Diabetes. J Am Coll Cardiol 2009;54:422-8. https://doi.org/10.1016/j.jacc.2009.04.049
  • van Riet EES, Hoes AW, Limburg A, Landman MAJ, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail 2014;16:772-7. https://doi.org/10.1002/ejhf.110
  • Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TRD, et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996;312:222-222. https://doi.org/10.1136/bmj.312.7025.222
  • Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrillo JE, et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002;112:437-45. https://doi.org/10.1016/S0002-9343(02)01048-3
  • Spinarová L. Changes in the ECG in chronic heart failure and after transplantation. Vnitr Lek 2003;49:730-3.
  • Baldasseroni S, Gentile A, Gorini M, Marchionni N, Marini M, Masotti G, et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J 2003;4:607-13. PMID: 14635378.
  • Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50. https://doi.org/10.1093/eurheartj/ehm037
  • Marwick TH, Raman S V., Carrió I, Bax JJ. Recent Developments in Heart Failure Imaging. JACC Cardiovasc Imaging 2010;3:429-39. https://doi.org/10.1016/j.jcmg.2010.02.002
  • Dokainish H, Nguyen JS, Bobek J, Goswami R, Lakkis NM. Assessment of the American Society of Echocardiography-European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study. Eur J Echocardiogr 2011;12:857-64. https://doi.org/10.1093/ejechocard/jer157
  • Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in Heart Failure. J Am Coll Cardiol 2007;50:381-96. https://doi.org/10.1016/j.jacc.2007.03.048
  • Nagueh SF, Bhatt R, Vivo RP, Krim SR, Sarvari SI, Russell K, et al. Echocardiographic Evaluation of Hemodynamics in Patients With Decompensated Systolic Heart Failure. Circ Cardiovasc Imaging 2011;4:220-7. https://doi.org/10.1161/CIRCIMAGING.111.963496
  • Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos GD, Barone D, et al. Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Hear J - Cardiovasc Imaging 2015. https://doi.org/10.1093/ehjci/jev083
  • Garbi M, McDonagh T, Cosyns B, Bucciarelli-Ducci C, Edvardsen T, Kitsiou A, et al. Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review. Eur Hear J - Cardiovasc Imaging 2015;16:147-53. https://doi.org/10.1093/ehjci/jeu299
  • Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003
  • Tanaka H, Nabeshima Y, Kitano T, Nagumo S, Tsujiuchi M, Ebato M, et al. Optimal timing of echocardiography for heart failure inpatients in Japanese institutions: OPTIMAL Study. ESC Hear Fail 2020;7:4213-21. https://doi.org/10.1002/ehf2.13050
  • Voigt J-U, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. J Am Soc Echocardiogr 2015;28:183-93. https://doi.org/10.1016/j.echo.2014.11.003
  • Poppe KK, Doughty RN, Gardin JM, Hobbs FDR, McMurray JJV, Nagueh SF, et al. Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function. JACC Cardiovasc Imaging 2015;8:656-65. https://doi.org/10.1016/j.jcmg.2015.02.014
  • Muraru D, Badano LP, Peluso D, Dal Bianco L, Casablanca S, Kocabay G, et al. Comprehensive Analysis of Left Ventricular Geometry and Function by ThreeDimensional Echocardiography in Healthy Adults. J Am Soc Echocardiogr 2013;26:618-28. https://doi.org/10.1016/j.echo.2013.03.014
  • Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G, et al. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Hear J - Cardiovasc Imaging 2014;15:680-90. https://doi.org/10.1093/ehjci/jet284
  • Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Remme EW, et al. A novel clinical method for quantification of regional left ventricular pressurestrain loop area: a non-invasive index of myocardial work. Eur Heart J 2012;33:724-33. https://doi.org/10.1093/eurheartj/ehs016.
  • Сафиуллина АА, Ускач ТМ, Саидова МА, Добровольская СВ, Терещенко СН. Новые подходы к оценке сократительной функции левого желудочка у пациентов с хронической сердечной недостаточностью на фоне модуляции сердечной сократимости. Кародиологический вестник 2020;3:4-13. https://doi.org/10.36396/MS.2020.16.3.001
  • Wang C-L, Chan Y-H, Wu VC-C, Lee H-F, Hsiao F-C, Chu P-H. Incremental prognostic value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and reduced ejection fraction. Eur Hear J - Cardiovasc Imaging 2021;22:348-56. https://doi.org/10.1093/ehjci/jeaa162
  • Hedwig F, Nemchyna O, Stein J, Knosalla C, Merke N, Knebel F, et al. Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure. Front Cardiovasc Med 2021;8. https://doi.org/10.3389/fcvm.2021.691611
  • Galli E, Hubert A, Le Rolle V, Hernandez A, Smiseth OA, Mabo P, et al. Myocardial constructive work and cardiac mortality in resynchronization therapy candidates. Am Heart J 2019;212:53-63. https://doi.org/10.1016/j.ahj.2019.02.008
  • Galli E, Leclercq C, Hubert A, Bernard A, Smiseth OA, Mabo P, et al. Role of myocardial constructive work in the identification of responders to CRT. Eur Hear J - Cardiovasc Imaging 2018;19:1010-8. https://doi.org/10.1093/ehjci/jex191
  • Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, et al. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation. Nat Commun 2018;9:374. https://doi.org/10.1038/s41467-017-02795-4
  • Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277-314. https://doi.org/10.1016/j.echo.2016.01.011
  • Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2019;40:3297-317. https://doi.org/10.1093/eurheartj/ehz641
  • Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A Simple, EvidenceBased Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation 2018;138:861-70. https://doi.org/10.1161/CIRCULATIONAHA.118.034646
  • Lancellotti P, Galderisi M, Edvardsen T, Donal E, Goliasch G, Cardim N, et al. EchoDoppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Hear J - Cardiovasc Imaging 2017;18:961-8. https://doi.org/10.1093/ehjci/jex067
  • Senni M, Rodeheffer RJ, Tribouilloy CM, Evans JM, Jacobsen SJ, Bailey KR, et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 1999;33:164-70. https://doi.org/10.1016/S0735-1097(98)00523-3
  • Agha SA, Kalogeropoulos AP, Shih J, Georgiopoulou V V., Giamouzis G, Anarado P, et al. Echocardiography and Risk Prediction in Advanced Heart Failure: Incremental Value Over Clinical Markers. J Card Fail 2009;15:586-92. https://doi.org/10.1016/j.cardfail.2009.03.002
  • Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135. https://doi.org/10.1161/CIR.0000000000000503
  • Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2014;27:911-39. https://doi.org/10.1016/j.echo.2014.07.012
  • Porter TR, Shillcutt SK, Adams MS, Desjardins G, Glas KE, Olson JJ, et al. Guidelines for the Use of Echocardiography as a Monitor for Therapeutic Intervention in Adults: A Report from the American Society of Echocardiography. J Am Soc Echocardiogr 2015;28:40-56. https://doi.org/10.1016/j.echo.2014.09.009
  • Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C, et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 2005;26:607-16. https://doi.org/10.1093/eurheartj/ehi083
  • Hoffmann R, Barletta G, von Bardeleben S, Vanoverschelde JL, Kasprzak J, Greis C, et al. Analysis of Left Ventricular Volumes and Function: A Multicenter Comparison of Cardiac Magnetic Resonance Imaging, Cine Ventriculography, and Unenhanced and Contrast-Enhanced Two-Dimensional and Three-Dimensional Echocardiography. J Am Soc Echocardiogr 2014;27:292-301. https://doi.org/10.1016/j.echo.2013.12.005
  • Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE. Performance of 3-Dimensional Echocardiography in Measuring Left Ventricular Volumes and Ejection Fraction. J Am Coll Cardiol 2012;59:1799-808. https://doi.org/10.1016/j.jacc.2012.01.037
  • Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, et al. Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;124:1527-36. https://doi.org/10.1161/CIRCULATIONAHA.110.014324
  • Thavendiranathan P, Liu S, Datta S, Walls M, Nitinunu A, Van Houten T, et al. Automated Quantification of Mitral Inflow and Aortic Outflow Stroke Volumes by Three-Dimensional Real-Time Volume Color-Flow Doppler Transthoracic Echocardiography: Comparison with Pulsed-Wave Doppler and Cardiac Magnetic Resonance Imaging. J Am Soc Echocardiogr 2012;25:56-65. https://doi.org/10.1016/j.echo.2011.10.004
  • Thavendiranathan P, Poulin F, Lim K-D, Plana JC, Woo A, Marwick TH. Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy. J Am Coll Cardiol 2014;63:2751-68. https://doi.org/10.1016/j.jacc.2014.01.073
  • Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, et al. Global Longitudinal Strain as a Major Predictor of Cardiac Events in Patients with Depressed Left Ventricular Function: A Multicenter Study. J Am Soc Echocardiogr 2010;23:1019-24. https://doi.org/10.1016/j.echo.2010.07.019
  • Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH. Normal Ranges of Left Ventricular Strain: A Meta-Analysis. J Am Soc Echocardiogr 2013;26:185-91. https://doi.org/10.1016/j.echo.2012.10.008
  • Stanton T, Leano R, Marwick TH. Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain. Circ Cardiovasc Imaging 2009;2:356-64. https:// https://doi.org/doi.org/10.1161/CIRCIMAGING.109.862334
  • Bansal M, Cho G-Y, Chan J, Leano R, Haluska BA, Marwick TH. Feasibility and Accuracy of Different Techniques of Two-Dimensional Speckle Based Strain and Validation With Harmonic Phase Magnetic Resonance Imaging. J Am Soc Echocardiogr 2008;21:1318-25. https://doi.org/10.1016/j.echo.2008.09.021
  • Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009;11:130-9. https://doi.org/10.1093/eurjhf/hfn013
  • Jolicœur EM, Dunning A, Castelvecchio S, Dabrowski R, Waclawiw MA, Petrie MC, et al. Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction. J Am Coll Cardiol 2015;66:2092-100. https://doi.org/10.1016/j.jacc.2015.08.882
  • 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2014;35:2541-619. https://doi.org/10.1093/eurheartj/ehu278
  • Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407-77. https://doi.org/10.1093/eurheartj/ehz425
  • Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van `t Veer M, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. N Engl J Med 2009;360:213-24. https://doi.org/10.1056/NEJMoa0807611
  • Toth G, De Bruyne B, Casselman F, De Vroey F, Pyxaras S, Di Serafino L, et al. Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery. Circulation 2013;128:1405-11. https://doi.org/10.1161/CIRCULATIONAHA.113.002740
  • Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. CoronaryArtery Bypass Surgery in Patients with Left Ventricular Dysfunction. N Engl J Med 2011;364:1607-16. https://doi.org/10.1056/NEJMoa1100356
  • Beller GA, Heede RC. SPECT Imaging for Detecting Coronary Artery Disease and Determining Prognosis by Noninvasive Assessment of Myocardial Perfusion and Myocardial Viability. J Cardiovasc Transl Res 2011;4:416-24. https://doi.org/10.1007/s12265-011-9290-2
  • Beanlands RSB, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease. J Am Coll Cardiol 2007;50:2002-12. https://doi.org/10.1016/j.jacc.2007.09.006
  • Angelidis G, Giamouzis G, Karagiannis G, Butler J, Tsougos I, Valotassiou V, et al. SPECT and PET in ischemic heart failure. Heart Fail Rev 2017;22:243-61. https://doi.org/10.1007/s10741-017-9594-7
  • Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145. https://doi.org/10.1161/CIR.0000000000001039
  • González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015;36:2585-94. https://doi.org/10.1093/eurheartj/ehv338
  • Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, et al. Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy. JACC Cardiovasc Imaging 2014;7:531-2. https://doi.org/10.1016/j.jcmg.2014.03.004
  • Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99m TcPyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses. Circ Cardiovasc Imaging 2013;6:195-201. https://doi.org/10.1161/CIRCIMAGING.112.000132
  • Seo M, Yamada T, Tamaki S, Watanabe T, Morita T, Furukawa Y, et al. Prognostic Significance of Cardiac 123I-MIBG SPECT Imaging in Heart Failure Patients With Preserved Ejection Fraction. JACC Cardiovasc Imaging 2022;15:655-68. https://doi.org/10.1016/j.jcmg.2021.08.003
  • Paeng JC, Choi JY. Nuclear Imaging for Cardiac Amyloidosis: Bone Scan, SPECT/ CT, and Amyloid-Targeting PET. Nucl Med Mol Imaging (2010) 2021;55:61-70. https://doi.org/10.1007/s13139-020-00681-4
  • Joseph V, Julien HM, Bravo PE. Radionuclide Imaging of Cardiac Amyloidosis. PET Clin 2021;16:285-93. https://doi.org/10.1016/j.cpet.2020.12.010
  • Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, et al. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Hear Fail 2019;7:709-16. https://doi.org/10.1016/j.jchf.2019.04.010
  • AlJaroudi WA, Desai MY, Tang WHW, Phelan D, Cerqueira MD, Jaber WA. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques. J Nucl Cardiol 2014;21:271-83. https://doi.org/10.1007/s12350-013-9800-5
  • Piepoli MF, Conraads V, Corrà U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 2011;13:347-57. https://doi.org/10.1093/eurjhf/hfr017
  • Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23
  • Kaminsky LA, Tuttle MS. Functional Assessment of Heart Failure Patients. Heart Fail Clin 2015;11:29-36. https://doi.org/10.1016/j.hfc.2014.08.002
  • Enright PL. The six-minute walk test. Respir Care 2003;48:783-5. PMID: 12890299.
  • Faggiano P, D’Aloia A, Gualeni A, Brentana L, Cas LD. The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail 2004;6:687-91. https://doi.org/10.1016/j.ejheart.2003.11.024
  • Zielińska D, Bellwon J, Rynkiewicz A, Elkady MA. Prognostic Value of the SixMinute Walk Test in Heart Failure Patients Undergoing Cardiac Surgery: A Literature Review. Rehabil Res Pract 2013;2013:1-5. https://doi.org/10.1155/2013/965494
  • Ingle L, Cleland JG, Clark AL. The Long-Term Prognostic Significance of 6-Minute Walk Test Distance in Patients with Chronic Heart Failure. Biomed Res Int 2014;2014:1-7. https://doi.org/10.1155/2014/505969
  • Ingle L, Cleland JG, Clark AL. The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Ann Phys Rehabil Med 2014;57:244-53. https://doi.org/10.1016/j.rehab.2014.03.004
  • Pollentier B, Irons SL, Benedetto CM, Dibenedetto A-M, Loton D, Seyler RD, et al. Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J 2010;21:13-21. PMID: 2046751.
  • Palau P, Domínguez E, Núñez E, Sanchis J, Santas E, Núñez J. Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment? Int J Cardiol 2016;203:800-2. https://doi.org/10.1016/j.ijcard.2015.11.074
  • Forman DE, Fleg JL, Kitzman DW, Brawner CA, Swank AM, McKelvie RS, et al. 6-Min Walk Test Provides Prognostic Utility Comparable to Cardiopulmonary Exercise Testing in Ambulatory Outpatients With Systolic Heart Failure. J Am Coll Cardiol 2012;60:2653-61. https://doi.org/10.1016/j.jacc.2012.08.1010
  • Corrà U, Piepoli MF, Adamopoulos S, Agostoni P, Coats AJS, Conraads V, et al. Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role. Eur J Heart Fail 2014;16:929-41. https://doi.org/10.1002/ejhf.156
  • Corrà U, Agostoni PG, Anker SD, Coats AJS, Crespo Leiro MG, de Boer RA, et al. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018;20:3-15. https://doi.org/10.1002/ejhf.979
  • Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease. J Am Coll Cardiol 2007;50:1914-31. https://doi.org/10.1016/j.jacc.2007.09.008
  • Cooper LT, Berry GJ, Shabetai R. Idiopathic Giant-Cell Myocarditis - Natural History and Treatment. N Engl J Med 1997;336:1860-6. https://doi.org/10.1056/NEJM199706263362603
  • Saric M, Armour AC, Arnaout MS, Chaudhry FA, Grimm RA, Kronzon I, et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. J Am Soc Echocardiogr 2016;29:1-42. https://doi.org/10.1016/j.echo.2015.09.011
  • ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. J Am Soc Echocardiogr 2011;24:229-67. https://doi.org/10.1016/j.echo.2010.12.008
  • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/ AHA Guideline for the Management of Heart Failure. Circulation 2013 Oct 15;128(16):e240-327. https://doi.org/10.1161/CIR.0b013e31829e8776
  • Obokata M, Kane GC, Reddy YN V., Olson TP, Melenovsky V, Borlaug BA. Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction. Circulation 2017;135:825-38. https://doi.org/10.1161/CIRCULATIONAHA.116.024822
  • Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2008;30:278-89. https://doi.org/10.1093/eurheartj/ehn492
  • Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8. https://doi.org/10.1016/S0735-1097(02)01726-6
  • Ling LF, Marwick TH, Flores DR, Jaber WA, Brunken RC, Cerqueira MD, et al. Identification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction. Circ Cardiovasc Imaging 2013;6:363-72. https://doi.org/10.1161/CIRCIMAGING.112.000138
  • Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. N Engl J Med 2011;364:1617-25. https://doi.org/10.1056/NEJMoa1100358
  • deFilippi CR, Willett DL, Brickner ME, Appleton CP, Yancy CW, Eichhorn EJ, et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995;75:191-4. https://doi.org/10.1016/S0002-9149(00)80078-8
  • Tribouilloy C, Lévy F, Rusinaru D, Guéret P, Petit-Eisenmann H, Baleynaud S, et al. Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography. J Am Coll Cardiol 2009;53:1865-73. https://doi.org/10.1016/j.jacc.2009.02.026
  • Clavel M-A, Fuchs C, Burwash IG, Mundigler G, Dumesnil JG, Baumgartner H, et al. Predictors of Outcomes in Low-Flow, Low-Gradient Aortic Stenosis. Circulation 2008 Sep 30;118(14 Suppl):S234-42. https://doi.org/10.1161/CIRCULATIONAHA.107.757427
  • Garnier F, Eicher J, Jazayeri S, Bertaux G, Bouchot O, Aho L, et al. Usefulness and limitations of contractile reserve evaluation in patients with low‐flow, low‐gradient aortic stenosis eligible for cardiac resynchronization therapy. Eur J Heart Fail 2014;16:648-54. https://doi.org/10.1002/ejhf.78
  • Erdei T, Smiseth OA, Marino P, Fraser AG. A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU‐FP7 MEDIA study group. Eur J Heart Fail 2014;16:1345-61. https://doi.org/10.1002/ejhf.184
  • Donal E, Lund LH, Oger E, Reynaud A, Schnell F, Persson H, et al. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study. Eur Hear J - Cardiovasc Imaging 2016 Jan;17(1):106-13. Epub 2015 Jun 16. PMID: 26082167. https://doi.org/10.1093/ehjci/jev144
  • Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2020;22:391-412. https://doi.org/10.1002/ejhf.1741
  • Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001;37:278-85. https://doi.org/10.1016/S0735-1097(00)01056-1
  • 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013;34:2949-3003. https://doi.org/10.1093/eurheartj/eht296
  • Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016;37:267-315. https://doi.org/10.1093/eurheartj/ehv320
  • Sousa PA, Bettencourt N, Dias Ferreira N, Carvalho M, Leite D, Ferreira W, et al. Role of cardiac multidetector computed tomography in the exclusion of ischemic etiology in heart failure patients. Rev Port Cardiol 2014;33:629-36. https://doi.org/10.1016/j.repc.2014.02.028
  • Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. J Cardiovasc Comput Tomogr 2022;16:54-122. https://doi.org/10.1016/j.jcct.2021.11.009
  • Chow BJW, Coyle D, Hossain A, Laine M, Hanninen H, Ukkonen H, et al. Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C). Eur Hear J - Cardiovasc Imaging 2021;22:1083-90. https://doi.org/10.1093/ehjci/jeaa109
  • Ferreira JP, Rossignol P, Demissei B, Sharma A, Girerd N, Anker SD, et al. Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart 2018;104:606-13. https://doi.org/10.1136/heartjnl-2017-311750
  • Sechtem U, Pflugfelder P, Higgins CB. Quantification of cardiac function by conventional and cine magnetic resonance imaging. Cardiovasc Intervent Radiol 1987;10:365-73. https://doi.org/10.1007/BF02577347
Еще
Статья научная